コレステロール濃度が低いアメリカ先住民の血清コレステロールと死亡率:U形の関連
A Fagot-Campagna1, R L Hanson, K M Narayan
1National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Ariz 85014, USA. fax@cu.nih.gov
Circulation
|October 7, 1997
まとめ
低血清コレステロールは,直接死の原因にはなりません. 代わりに,病気によってコレステロールレベルが低下し,ピマ・インディアンの死亡率が高いとの関連が見られる.
科学分野:
- エピデミオロジー エピデミオロジー
- バイオケミストリー バイオケミストリー
背景:
- 低血清コレステロールは,癌,トラウマ,感染症による死亡率の増加と論争の的になっている.
- 低コレステロールと死亡率の因果関係は,さらなる調査を必要としています.
研究 の 目的:
- 低血清コレステロールが全原因または特定原因による死亡の因果要因であるかどうかを評価する.
- ピマ・インディアンの集団におけるコレステロールレベルと死亡率の複雑な関係を調査する.
主な方法:
- 4553人のピマ・インディアン (年齢>=20) の長期的研究で,追跡期間の中央値は12.8年であった.
- 血清コレステロールは2年ごとに測定され,死亡率は比例リスクモデルを用いて分析された.
- 統計分析における潜在的な混同要因に調整した.
主要な成果:
- 血清コレステロールと全死因の死亡率の間にU形の関係が観察されました.
- コレステロールと心血管疾患/糖尿病の死亡率の間の肯定的な関連性が見つかりました.
- コレステロールと癌/アルコール関連疾患による死亡率の間の否定的な関連性; 感染症のU型.
結論:
- 低コレステロールと高い死亡率との間の観察された関連は,低コレステロールが病気を引き起こすのではなく,コレステロールを低下させる疾患によるものである可能性が高い.
- これは,病気が先行し,コレステロールレベルに影響を与える逆因果関係を示唆しています.
関連する概念動画
Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

